A device to assist the performance of a heart with at least one pump that is formed as a rotary pump and driven via a magneto coupling.
|
1. A system for assisting the blood circulation of a heart, comprising:
a heart assist pump device deliverable to the heart and comprising:
an inflow tube defining a blood inflow path and having a suction end insertable into a ventricle of the heart;
a magnetically driven rotor axially aligned with the inflow tube and being spaced apart from the suction end when the suction end of the inflow tube is inserted into the ventricle, the magnetically driven rotor being rotatable within a surrounding rotor housing to act upon blood flowing from the inflow tube toward the rotor, the magnetically driven rotor being rotatable about a central axis and being rigidly coupled to and axially adjacent to a first magnetic device that is located within the surrounding rotor housing;
a second magnetic device axially aligned with the inflow tube and positioned to magnetically drive rotation of the magnetically driven rotor via a magneto coupling with the first magnetic device while being spaced apart and sealed from both the magnetically driven rotor and the first magnetic device by at least one sealing wall, the second magnetic device being positioned axially spaced apart from the magnetically driven rotor;
a blood outflow port positioned radially adjacent the magnetically driven rotor such that blood driven by the magnetically driven rotor is configured to exit the surrounding rotor housing in a direction transverse to the central axis of the magnetically driven rotor, wherein when the magnetically driven rotor is rotated, the magnetically driven rotor remains adjacent to and spaced apart from the surrounding rotor housing by the blood flowing from the inflow tube and to the blood outflow port; and
an external control unit configured to regulate operation of the second magnetic device, wherein the external control unit is connectable to the heart assist pump device for controlling the second magnetic device to thereby magnetically drive the rotation of the magnetically driven rotor via the magneto coupling with the first magnetic device.
21. A system for assisting blood circulation of a heart, the system comprising:
a heart assist pump device deliverable to the heart and comprising:
an inflow tube defining a blood inflow path along an inflow axis and being insertable into a left ventricle;
one or more walls at least partially defining a chamber to receive blood from the inflow tube;
a magnetically driven rotor axially aligned with the inflow axis and being rigidly coupled and axially adjacent to a first magnetic device that is axially aligned with the inflow axis, the magnetically driven rotor and first magnetic device being rotatable about an axis of rotation aligned with the inflow axis to drive the blood flowing from the inflow tube;
a magnetic drive system comprising a second magnetic device axially aligned with the inflow axis and spaced apart from the magnetically driven rotor such that a wall of the one or more walls defining the chamber is positioned between the magnetically driven rotor and the second magnetic device, the second magnetic device positioned axially closer to the first magnetic device than to the magnetically driven rotor so as to magnetically drive rotation of the magnetically driven rotor within the chamber via a magneto coupling with the first magnetic device; and
a blood outflow port positioned radially outward of the magnetically driven rotor such that the blood driven by the magnetically driven rotor exits the chamber in a direction transverse to the inflow axis, wherein the magneto coupling orients the magnetically driven rotor so that both the magnetically driven rotor and the first magnetic device remain spaced apart from the one or more walls by the blood in response to rotation of the magnetically driven rotor; and
an external control unit configured to control operation of the second magnetic device based on a control value indicative of a defined cardiac output, wherein the external control unit is connectable to the heart assist pump device for controlling the second magnetic device to thereby magnetically drive the rotation of the magnetically driven rotor via the magneto coupling with the first magnetic device.
2. The system of
3. The system of
4. The system of
5. The system of
6. The system of
7. The system of
10. The system of
11. The system of
12. The system of
13. The system of
14. The system of
15. The system of
16. The system of
19. The system of
20. The system of
22. The system of
23. The system of
24. The system of
26. The system of
28. The system of
29. The system of
32. The system of
33. The system of
34. The system of
37. The system of
|
This application is a continuation of and claims priority to U.S. application Ser. No. 17/446,046 filed on Aug. 26, 2021, which is a continuation of U.S. application Ser. No. 16/282,948 filed on Feb. 22, 2019 (now U.S. Pat. No. 11,123,540), which is a continuation of U.S. application Ser. No. 14/454,965 filed on Aug. 8, 2014 (now U.S. Pat. No. 10,251,984), which is a continuation of U.S. application Ser. No. 13/555,318 filed on Jul. 23, 2012 (now U.S. Pat. No. 8,801,590), which is a divisional of U.S. application Ser. No. 12/449,632 filed on Aug. 18, 2009 (now U.S. Pat. No. 8,255,050), which is the U.S. national phase of International Application PCT/IB2008/000421 filed on Feb. 27, 2008, which designated the U.S. and claims benefit of AT A 306/2007 filed Feb. 27, 2007, the entire contents of these prior applications are hereby incorporated by reference.
After a heart failure, for example a cardiac infarction or other reasons for the decrease in the performance of a heart, it is of essential importance for intensive care medicine to normalise and stabilise the cardiac function again as rapidly as possible. When for example the volume output of the heart is distinctly reduced as a result of a failure, it is particularly important to reliably and rapidly re-establish a corresponding peripheral blood flow in order to prevent secondary damage. The use of heart-lung machines basically allows the essential vital functions to be maintained. A specific adaptation to the respective actual requirements generally does not take place with such devices, however. Rather, conventional heart-lung machines are devices which, using external pumps, maintain a forced circulation of blood without systematically entering into the respective requirements of the heart which has been weakened or subjected to a failure.
In surgical interventions, particularly in the vein area, it has already been proposed to carry out retroinfusion, controlled by venous pressure, from or in veins of the body with the suction″of fluid and return of the fluid via a pump. Conventional catheters are used here, the lumina of which allow a suction of fluid and via the lumina of which the return is made possible at a suitable site. Known devices, particularly for the retroinfusion of blood in coronary veins in the area of myocardial protection during a brief coronary artery closure within a cardiological intervention, are generally devised so that a balloon dilatation of an arteriosclerotically constricted coronary artery is carried out. In these cases, a compensation which is adapted to the intervention briefly taking place respectively can be carried out by the return of blood which has been drawn off in veins. For a continuous restitution of the full function of a heart, however, the criteria are not taken into account which would be relevant for the full function of the heart, and an intensive provision over a particular period of time is therefore not provided with such devices. At the same time, the provision of the other organs must also be maintained.
In the device known from AT 407 960 B for assisting the performance of a heart, fluid is removed from blood vessels via an external pump and is returned into blood vessels via a return catheter, in which the returned quantity of fluid is regulated as a function of measurement values, with a heart ventricle catheter being provided to obtain these measurement values. The known device comprised a heart ventricle catheter which is equipped in the cardiac chamber with sensors to measure the volume of fluid per unit of time, in which these sensors, in the introduced state of the heart ventricle catheter, lie in the cardiac chamber and these sensors are connected with an evaluation circuit in which the ratio of the diastolic volume to the systolic volume is evaluated per heartbeat or per unit of time in particular the discharge rate and/or the deviation of the volume conveyed per unit of time by the heart from a defined rated value is evaluated, for example the rated value, calculated from physically specific data for the cardiac output. The signal which is generated in this way is passed to the pump, via which fluid is withdrawn from the cardiac chamber and is recirculated as a function of the generated signal.
A fluid flow which is improved by the pump is to be developed in a way in which the mechanical stress of highly sensitive fluids, such as blood for example, can be kept as low as possible and nevertheless the corresponding improvement to circulation can be ensured at desired locations. A completely impervious separation of the rotor from the drive wheel is achieved by a magneto coupling which is provided according to the invention, which eliminates axial passages between the drive wheel and the rotor lying distally on the outside.
The rotor itself can follow design principles such as described for example in WO 01/70300 A1. The rotary pump shown and described there for conveying blood and other highly sensitive fluids is formed as an external electromagnetically driven pump which is not directly suitable for incorporation into a catheter. However, for the desired conveying capacity with the axial pump according to the invention, provision is also made according to the invention that the rotor has guide surfaces to produce centrifugal flow components.
The driving fluid can be used within the scope of the invention in order to be able to operate a balloon for retroperfusion. The embodiment is preferably devised hereby so that the lumina for the driving fluid are guided through an expandable balloon surrounding the catheter in a sealing manner, and that the lumina have separately controllable closure members via which driving fluid can arrive in the balloon or out of the balloon into the respective lumina, in which preferably the closure members are formed as magneto valves. On inflation of the balloon, additional driving medium is required which can be discharged again on collapsing of the balloon. This is possible extracorporally on the drive side by means of a reservoir.
The embodiment to assist the performance of a heart according to the invention, in which fluid is conveyed in blood vessels with the use of a pump and the conveyed quantity is able to be regulated as a function of measurement values of a heart ventricle catheter, from which the cardiac output is determined, proceeds from a development according to AT 407 960 B and is characterised substantially in that the pump is formed as an intravasal rotary pump at the periphery or at the distal end of the catheter, the rotor of which, lying on the outside, is connected via a magneto coupling with the drive which is arranged inside the catheter.
The invention is explained in further detail below by use of an examplary embodiment which is illustrated diagrammatically in the drawings, in which
In
The volumetric measurement in the cardiac chamber allows differences to be reliably detected between the diastolic and systolic volume and allows corresponding correction signals to be made available for the output of the synchronised fluid pump 7. Furthermore, in the control circuit 5, corresponding fixed values can be provided, such as for example a defined cardiac output, which is referred to on deviation of the measured cardiac output to control the pump.
A retroperfusion can take place via a conventional balloon catheter which is occluded in a correspondingly synchronized manner, so that the directed return is in fact guaranteed during the diastole. Hereby the corresponding measurement values for the heart rate or for the correct moment of the diastole can be obtained from ECG data.
In
In
Patent | Priority | Assignee | Title |
12064615, | May 30 2018 | Robert Bosch GmbH | Axial-flow pump for a ventricular assist device and method for producing an axial-flow pump for a ventricular assist device |
12076549, | Jul 20 2018 | Robert Bosch GmbH | Feed line for a pump unit of a cardiac assistance system, cardiac assistance system and method for producing a feed line for a pump unit of a cardiac assistance system |
12107474, | May 16 2018 | Robert Bosch GmbH | End-face rotating joint for transmitting torques |
12144976, | Jun 21 2018 | Robert Bosch GmbH | Method and device for detecting a wear condition of a ventricular assist device and for operating same, and ventricular assist device |
12178554, | Jun 06 2018 | Robert Bosch GmbH | Systems and methods for determining a viscosity of a fluid |
ER302, |
Patent | Priority | Assignee | Title |
4135253, | Nov 30 1976 | HEMADYNE CORPORATION A CORP OF MN | Centrifugal blood pump for cardiac assist |
4674518, | Sep 06 1985 | Cardiac Pacemakers, Inc. | Method and apparatus for measuring ventricular volume |
4895557, | Dec 07 1987 | Medtronic, Inc | Drive mechanism for powering intravascular blood pumps |
5308319, | Dec 28 1989 | Sumitmo Bakelite Company Limited | Cardio assist system and insertion device therefor |
5449342, | Sep 30 1991 | NIPPON ZEON CO , LTD | Apparatus for assisting blood circulation |
5470208, | Oct 05 1990 | Fluid pump with magnetically levitated impeller | |
5503615, | Aug 26 1994 | Implantable cardiac ventricular assist device and controller thereof | |
5601418, | Apr 28 1993 | Kyocera Corporation; Baylor College of Medicine | Blood pump |
5921913, | Apr 03 1996 | Impella Cardiosystems GmbH | Statorless intravascular microaxial flow pump |
5928131, | Nov 26 1997 | Vascor, Inc | Magnetically suspended fluid pump and control system |
5964694, | Apr 02 1997 | Impella Cardiosystems GmbH | Method and apparatus for cardiac blood flow assistance |
6007478, | Nov 13 1997 | Impella Cardiosystems GmbH | Cannula having constant wall thickness with increasing distal flexibility and method of making |
6083260, | Jul 11 1997 | MAQUET CARDIOVASCULAR, LLC, A DELAWARE CORPORATION | Reverse flow transport pump and organ stabilization apparatus including related methods |
6155969, | Jul 29 1996 | KYOCERA CORPORATION A K A KYOCERA; HEINRICH SCHIMA | Centrifugal pump for pumping blood and other shear-sensitive liquids |
6176848, | Apr 04 1996 | Impella Cardiosystems GmbH | Intravascular blood pump |
6506146, | Sep 22 1997 | MIRACOR MEDIZINTECHNIK HANDELS--UND ENTWICKLUNGSGMBH | Apparatus for supporting heart performance |
6508787, | Sep 26 1995 | Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung E.V. | System for actively supporting the flow of body fluids |
6540658, | May 30 2000 | ABIOMED, INC | Left-right flow control algorithm in a two chamber cardiac prosthesis |
6623475, | Dec 02 1998 | Impella Cardiosystems GmbH | Blood pump without bearing |
7699586, | Dec 03 2004 | Boston Scientific Scimed, Inc | Wide blade, axial flow pump |
8255050, | Feb 27 2007 | Miracor Medical Systems GmbH | Catheter to assist the performance of a heart |
8512012, | Mar 18 2004 | CIRCULITE, INC | Pump |
9616157, | Aug 06 2006 | Blood pump | |
20010039369, | |||
20040236420, | |||
20060089521, | |||
20080214888, | |||
20110238172, | |||
DE3616857, | |||
EP75606, | |||
EP503839, | |||
EP1011753, | |||
EP1034808, | |||
EP1727987, | |||
FR1187249, | |||
GB2347085, | |||
JP2005348996, | |||
WO199320860, | |||
WO199737698, | |||
WO199915213, | |||
WO200044417, | |||
WO200170300, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 30 2009 | MOHL, WERNER | Miracor Medical Systems GmbH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 062353 | /0319 | |
Mar 07 2018 | Miracor Medical Systems GmbH | Miracor Medical SA | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 062353 | /0328 | |
Dec 22 2022 | Miracor Medical SA | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Dec 22 2022 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Jan 12 2023 | SMAL: Entity status set to Small. |
Date | Maintenance Schedule |
Jun 13 2026 | 4 years fee payment window open |
Dec 13 2026 | 6 months grace period start (w surcharge) |
Jun 13 2027 | patent expiry (for year 4) |
Jun 13 2029 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 13 2030 | 8 years fee payment window open |
Dec 13 2030 | 6 months grace period start (w surcharge) |
Jun 13 2031 | patent expiry (for year 8) |
Jun 13 2033 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 13 2034 | 12 years fee payment window open |
Dec 13 2034 | 6 months grace period start (w surcharge) |
Jun 13 2035 | patent expiry (for year 12) |
Jun 13 2037 | 2 years to revive unintentionally abandoned end. (for year 12) |